Dobi Medical on track with breast cancer imager
This article was originally published in Clinica
Executive Summary
Dobi Medical International says it is on track with plans to submit a US marketing application for its angiogenesis-based breast cancer imaging system next summer. The Mahwah, New Jersey firm has begun a clinical trial which will be the subject of the fifth and final module of its premarket approval (PMA) application with the FDA for its flagship product, the ComfortScan system. Patient enrolment has now started at several leading medical centres, with additional sites expected to begin enrolling patients in early 2005.